These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome]. Renz-Polster H; Scheibenbogen C Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
25. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964 [TBL] [Abstract][Full Text] [Related]
26. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome. Maes M Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898 [TBL] [Abstract][Full Text] [Related]
27. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle? Kavyani B; Lidbury BA; Schloeffel R; Fisher PR; Missailidis D; Annesley SJ; Dehhaghi M; Heng B; Guillemin GJ Cell Mol Life Sci; 2022 Jul; 79(8):412. PubMed ID: 35821534 [TBL] [Abstract][Full Text] [Related]
28. Shadow Burden of Undiagnosed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) on Society: Retrospective and Prospective-In Light of COVID-19. Araja D; Berkis U; Lunga A; Murovska M J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300183 [TBL] [Abstract][Full Text] [Related]
29. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground? Ryabkova VA; Gavrilova NY; Fedotkina TV; Churilov LP; Shoenfeld Y Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611357 [TBL] [Abstract][Full Text] [Related]
30. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM Front Immunol; 2019; 10():796. PubMed ID: 31057538 [TBL] [Abstract][Full Text] [Related]
31. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study. Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005 [TBL] [Abstract][Full Text] [Related]